Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
British Journal of Cancer|January 6, 2017
Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growthKarla Parra, Paloma Valenzuela, Natzidielly Lerma, et al.Breast (Edinburgh, Scotland)|November 26, 2016
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patientsLuigi Coltelli, Andrea Fontana, Sara Lucchesi, et al.Critical Reviews in Oncology/Hematology|July 1, 2023
The impact of survivorship bias in glioblastoma researchFrancesco Pasqualetti, Alessandro Barberis, Sofia Zanotti, et al.Oncotarget|September 5, 2015
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patientsAnna Solini, Vittorio Simeon, Lisa Derosa, et al.Biochemical Pharmacology|April 5, 2011
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cellsGuido Bocci, Anna Fioravanti, Concettina La Motta, et al.Molecular Neurobiology|February 3, 2017
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-ChemotherapyFrancesco Pasqualetti, Paola Orlandi, Vittorio Simeon, et al.Journal of Clinical Medicine|November 25, 2023
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. <i>J. Clin. Med.</i> 2022, <i>11</i>, 7162Guido Bocci, Sabrina Pelliccia, Paola Orlandi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancerAndrea Fontana, Luca Galli, Anna Fioravanti, et al.Investigational New Drugs|April 28, 2019
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphomaM Christina Cox, Sabrina Pelliccia, Luigi Marcheselli, et al.Journal of Clinical Medicine|December 11, 2022
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell LymphomaGuido Bocci, Sabrina Pelliccia, Paola Orlandi, et al.Pageof 16